连续多次注射大环状钆基对比剂(钆布醇)后钆沉积的评估:单中心189例患者经验
回顾性纳入2009年8月至2016年8月间仅使用钆布醇行至少2次增强MR扫描的189例患者,计算末次与首次MR图像上齿状核/脑桥及苍白球/丘脑信号强度比值的差值。齿状核/脑桥比值差值均值-0.012±0.115(P=0.148),苍白球/丘脑比值差值均值0.012±0.111(P=0.126),均与0无显著差异。结论认为连续注射钆布醇未导致齿状核或苍白球T1WI信号增高。
要点
- 连续注射钆布醇后齿状核/脑桥信号比值差值均值为-0.012±0.115(P=0.148),与0无显著差异。
- 苍白球/丘脑信号比值差值均值为0.012±0.111(P=0.126),与0无显著差异。
- 患者平均接受5.9±6.3次增强MR扫描,平均间隔42.8±49.5周。
核心结论
- 连续多次注射钆布醇未导致非增强T1加权MR图像上齿状核或苍白球信号增高,未提示钆沉积。
研究设计与样本
- 单中心回顾性研究,纳入189例在2009年8月至2016年8月间仅使用钆布醇行至少2次增强MR扫描的患者,计算末次与首次非增强T1加权MR图像上齿状核/脑桥和苍白球/丘脑信号强度比值的差值。
关键影像表现/征象
- 齿状核/脑桥信号强度比值差值均值为-0.012±0.115(P=0.148),与0无显著差异。
- 苍白球/丘脑信号强度比值差值均值为0.012±0.111(P=0.126),与0无显著差异。
诊断标准与关键数值
- 采用单样本t检验评估信号强度比值差值是否与0存在差异。
- 采用线性回归和Pearson相关分析评估信号强度比值差值与扫描次数、平均扫描间隔时间、年龄、性别、放疗或化疗史、肾功能和肝功能等混杂变量的相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: There has been controversy as to whether gadobutrol, one of the widely used macrocyclic gadolinium-based contrast agents, can lead to gadolinium retention after serial injections. Our aim was to validate whether serial administrations of gadobutrol can cause signal increase in the dentate nucleus (DN) and globus pallidus (GP) on unenhanced T1-weighted magnetic resonance (MR) images due to gadolinium retention.
MATERIALS AND METHODS: A total of 189 patients who had undergone at least 2 contrast-enhanced MR scans using only gadobutrol between August 2009 and August 2016 were retrospectively included. The DN-to-pons and GP-to-thalamus signal intensity (SI) ratio differences on unenhanced T1-weighted MR images were calculated by subtracting the SI ratios at the first MR images from those at the last MR images. One-sample t tests were used to evaluate whether the SI ratio differences differed from 0. Linear regression and Pearson correlations were performed to assess correlations between SI ratio differences and various confounding variables, including the number of MR scans, mean time interval between MR scans, age, sex, history of radiation therapy or chemotherapy, and renal and liver functions.
RESULTS: Patients underwent a mean of 5.9 ± 6.3 contrast-enhanced MR scans with a mean interval of 42.8 ± 49.5 weeks between the scans. Sixty-three patients underwent 6 or more MR scans, whereas 126 patients underwent fewer than 6 MR scans. Neither the DN-to-pons SI nor the GP-to-thalamus SI ratio differences differed significantly from 0, with mean values of -0.012 ± 0.115 (P = 0.148) and 0.012 ± 0.111 (P = 0.126), respectively.
CONCLUSIONS: Serial administrations of gadobutrol did not result in signal increases in the DN or GP on unenhanced T1-weighted MR images due to gadolinium retention.
引用
- Yoo RE, Sohn CH, Kang KM, et al. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients. Invest Radiol. 2018. PMID: 28742734. doi:10.1097/RLI.0000000000000404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。